Cardioversion and Risk of Adverse Events with Dabigatran versus Warfarin—A Nationwide Cohort Study

AIM: Cardioversion can rapidly and effectively restore sinus rhythm in patients with persistent atrial fibrillation. Since 2011 dabigatran has been available as an alternative to warfarin to prevent thromboembolic events in patients with non-valvular atrial fibrillation undergoing cardioversion. We...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:PLoS One
Huvudupphovsmän: Pallisgaard, Jannik Langtved, Lindhardt, Tommi Bo, Hansen, Morten Lock, Schjerning, Anne-Marie, Olesen, Jonas Bjerring, Staerk, Laila, Torp-Pedersen, Christian, Gislason, Gunnar Hilmar
Materialtyp: Artigo
Språk:Inglês
Publicerad: Public Library of Science 2015
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4625957/
https://ncbi.nlm.nih.gov/pubmed/26513589
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0141377
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk